Verano Holdings Corp.
General ticker "VRNOF" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $363.4M (TTM average)
Verano Holdings Corp. follows the US Stock Market performance with the rate: 34.5%.
Estimated limits based on current volatility of 5.9%: low 0.92$, high 1.04$
Factors to consider:
- Total employees count: 3800 (-2.6%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Litigation risks, Economic downturns and volatility, Liquidity and credit risks, Dependence on key management, Market acceptance
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.73$, 2.20$]
- 2025-12-31 to 2026-12-31 estimated range: [0.65$, 1.84$]
Financial Metrics affecting the VRNOF estimates:
- Positive: with PPE of -5.6 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: Operating cash flow per share per price, % of 26.02 > 13.24
- Positive: 41.86 < Shareholder equity ratio, % of 47.87 <= 63.39
- Positive: Industry inventory ratio change (median), % of -1.41 <= -0.15
Short-term VRNOF quotes
Long-term VRNOF plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $880.97MM | $938.15MM | $878.59MM |
| Operating Expenses | $1,042.10MM | $853.36MM | $1,115.76MM |
| Operating Income | $-161.13MM | $84.78MM | $-237.18MM |
| Non-Operating Income | $-2.27MM | $-56.99MM | $-62.74MM |
| Interest Expense | $49.43MM | $59.79MM | $54.76MM |
| Income(Loss) | $-163.40MM | $27.80MM | $-299.92MM |
| Taxes | $105.47MM | $145.15MM | $41.94MM |
| Profit(Loss)* | $-269.16MM | $-117.35MM | $-341.86MM |
| Stockholders Equity | $1,341.55MM | $1,240.08MM | $952.17MM |
| Inventory | $164.53MM | $140.69MM | $184.46MM |
| Assets | $2,396.05MM | $2,318.74MM | $1,988.96MM |
| Operating Cash Flow | $94.35MM | $109.71MM | $112.19MM |
| Capital expenditure | $119.17MM | $36.33MM | $99.05MM |
| Investing Cash Flow | $-207.85MM | $-47.40MM | $-133.25MM |
| Financing Cash Flow | $99.25MM | $27.60MM | $-65.93MM |
| Earnings Per Share** | $-0.81 | $-0.34 | $-0.98 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.